The US Food and Drug Administration (FDA) has released new draft guidance to enhance racial, ethnic, and other forms of diversity in clinical trials conducted by drugmakers and medical device manufacturers. The recommendations offer a structured approach for companies...
In a groundbreaking revelation, researchers have uncovered that obesity drugs, traditionally prescribed for weight management, could play a significant role in combating substance abuse. This dual functionality of obesity medications is poised to revolutionise the...
The South African Border Management Authority (BMA) has activated its outbreak preparedness plan in response to the rising cases of Mpox. The National Department of Health has confirmed 13 cases across the country. Yesterday, BMA commissioner Dr Michael Masiapato...
Early results from the Phase 3 PURPOSE 1 trial reveal that an injectable antiretroviral drug, administered twice a year, can effectively prevent HIV infection in cisgender women. Professor Thesla Palanee-Phillips, director of clinical trials at Wits RHI, hailed the...
Seventy percent of foreign-trained doctors who took board exams in October 2023 and February 2024 failed. However, around 250 junior doctors have identified discrepancies in their examination scripts. They are now seeking intervention from the Information Regulator to...
